Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia

INTRODUCTION: Despite their unfavourable cardiovascular risk profile, patients with glycogen storage disease type Ia (GSD Ia) do not develop premature atherosclerosis. We hypothesized that this paradox might be related to a decreased formation of advanced glycation end products (AGEs) resulting from...

Descripción completa

Detalles Bibliográficos
Autores principales: den Hollander, N. C., Mulder, D. J., Graaff, R., Thorpe, S. R., Baynes, J. W., Smit, G. P. A., Smit, A. J.
Formato: Texto
Lenguaje:English
Publicado: Springer Netherlands 2007
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799632/
https://www.ncbi.nlm.nih.gov/pubmed/17570077
http://dx.doi.org/10.1007/s10545-007-0507-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799632/
https://www.ncbi.nlm.nih.gov/pubmed/17570077
http://dx.doi.org/10.1007/s10545-007-0507-0

Ejemplares similares